Michael Andersson

17.2k citations
124 papers · 8.1k · 4 hit papers · h-index 38

Impact in

    • Breast Cancer Treatment Studies
  • Oncology top 0.5%
    • HER2/EGFR in Cancer Research
    • Cancer Treatment and Pharmacology

Papers in

    • HER2/EGFR in Cancer Research 23
    • Cancer Treatment and Pharmacology 16
    • Breast Cancer Treatment Studies 22

Michael Andersson

121 papers receiving 7.7k citations

Michael Andersson's Hit Papers

Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study 2009 · 520 citations
5200+9+18Years since publication4008001.2k

Peers

Michael Andersson
Comparison fields: 5 of 131
  • Cancer Research 1.8k
  • Oncology 2.5k
  • Pathology and Forensic Medicine 1.2k
  • Radiology, Nuclear Medicine and Imaging 983
  • Pulmonary and Respiratory Medicine 1.3k
Replace Graça M. Dores with:
Graça M. Dores United States
Bernard Asselain France
Heinz Schmidberger Germany
Steven E. Come United States
Alan Horwich United Kingdom
Wim L.J. van Putten Netherlands
Constance Cirrincione United States
Walter M. Gregory United Kingdom
Samuel Hellmän United States
Milena Sant Italy
Michael Andersson relative to Graça M. Dores United States Graça M. Dores's profile →
Citations per field
00.5×1.5×2.5×
Graça M. Dores · 1×
Citations per year

Countries citing papers authored by Michael Andersson

Since Specialization
Citations

This map shows the geographic impact of Michael Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Andersson more than expected).

Fields of papers citing papers by Michael Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Andersson. The network helps show where Michael Andersson may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Andersson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Andersson Line = papers co-authored together Michael Andersson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial
Hit paper breakdown →
19991249
2
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Hit paper breakdown →
2005606
3
Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study
Hit paper breakdown →
2009520
4
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
Hit paper breakdown →
2003502
5 2002445
6 1997366
7 1999278
8 2000278
9 2007271
10 2007263
11 2010225
12 2003171
13 2011145
14 2007138
15 2009132
16 2017113
17 2011113
18 2017113
19 2008112
20 2008103

About Michael Andersson

Michael Andersson is a scholar working on Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 124 papers that have together received 8.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (23 papers), Breast Cancer Treatment Studies (22 papers), Cancer Treatment and Pharmacology (16 papers), Radiation Dose and Imaging (9 papers), Effects of Radiation Exposure (6 papers), Urinary Bladder and Prostate Research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (2.5k citations), Pathology and Forensic Medicine (1.2k citations), Radiology, Nuclear Medicine and Imaging (983 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Michael Andersson has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Hans H. Storm, ­Eero Pukkala, Lois B. Travis, Charles F. Lynch, Eric J. Holowaty, Mary Gospodarowicz, Maj‐Britt Jensen, Claus Kamby, Per Hall and John D. Boice. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, Acta Oncologica, European Journal of Cancer and Radiation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact